€23.96
0.25% today
Xetra, Dec 18, 05:35 pm CET
ISIN
DE000A3ENQ51
Symbol
1SXP
Index
Sector
Industry

SCHOTT Pharma Stock price

€23.96
-1.66 6.48% 1M
-3.26 11.98% 6M
-9.64 28.69% YTD
-8.24 25.59% 1Y
-7.34 23.45% 3Y
-7.34 23.45% 5Y
-7.34 23.45% 10Y
Xetra, Closing price Wed, Dec 18 2024
+0.06 0.25%
ISIN
DE000A3ENQ51
Symbol
1SXP
Index
Sector
Industry

Key metrics

Market capitalization €3.60b
Enterprise Value €3.66b
P/E (TTM) P/E ratio 24.05
EV/FCF (TTM) EV/FCF 45.62
EV/Sales (TTM) EV/Sales 3.83
P/S ratio (TTM) P/S ratio 3.76
P/B ratio (TTM) P/B ratio 4.55
Dividend yield 0.63%
Last dividend (FY24) €0.15
Revenue (TTM) Revenue €957.09m
EBIT (operating result TTM) EBIT €173.37m
Free Cash Flow (TTM) Free Cash Flow €80.25m
Cash position €26.43m
EPS (TTM) EPS €0.99
P/E forward 23.08
P/S forward 3.48
EV/Sales forward 3.54
Show more

Is SCHOTT Pharma a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,895 stocks worldwide.

SCHOTT Pharma Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a SCHOTT Pharma forecast:

4x Buy
40%
6x Hold
60%

Analyst Opinions

10 Analysts have issued a SCHOTT Pharma forecast:

Buy
40%
Hold
60%

Financial data from SCHOTT Pharma

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
957 957
-
100%
- Direct Costs 634 634
-
66%
323 323
-
34%
- Selling and Administrative Expenses 60 60
-
6%
- Research and Development Expense 24 24
-
3%
238 238
-
25%
- Depreciation and Amortization 65 65
-
7%
EBIT (Operating Income) EBIT 173 173
-
18%
Net Profit 150 150
-
16%

In millions EUR.

Don't miss a Thing! We will send you all news about SCHOTT Pharma directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

SCHOTT Pharma Stock News

AD HOC NEWS
3 days ago
Die Privatbank Berenberg hat das Kursziel für Schott Pharma DE000A3ENQ51 von 32 auf 28 Euro gesenkt, aber die Einstufung auf "Hold" belassen.
EQS
7 days ago
Gesundheit ist entscheidend. Deshalb entwickelt SCHOTT Pharma wissenschaftlich fundierte Lösungen, die gewährleisten, dass Medikamente für Menschen auf der ganzen Welt sicher und einfach zu verwenden sind. Das Portfolio umfasst Aufbewahrungs- und Verabreichungssysteme für Medikamente, etwa vorfül...
AD HOC NEWS
7 days ago
Die Aktien von Schott Pharma DE000A3ENQ51 werden am Donnerstag nach Zahlen und einem Ausblick auf das neue Geschäftsjahr mit Gewinnen erwartet.
More SCHOTT Pharma News

Company Profile

Head office Germany
CEO Andreas Reisse
Employees 4,689
Founded 2022
Website www.schott.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today